Skip to nav Skip to content

Research and clinical trials that will change the way cancer is diagnosed and treated is the talk of Florida this week. More than 20,000 cancer physicians and scientists are in Orlando for the American Association for Cancer Research Annual Meeting. The yearly event brings together clinicians, researchers, patients, survivors and advocates to share the latest advances in cancer science and medicine. All aspects of the cancer continuum from population science and prevention; to cancer biology, translational research and clinical trials; to advocacy and survivorship are being discussed.

Some of the big discoveries revealed at this year’s meeting focus on clinical trials that could soon lead to new standard of care therapies for several cancers, including melanoma, non-small cell lung cancer and advanced biliary tract cancer. Several presentations highlight the impact of cancer disparities among individuals and communities.

Moffitt Cancer Center is well represented at the meeting. More than 130 scientists, postdoctoral fellows and students are at the Orange County Convention Center. Collectively, they are participating in 17 major and mini symposia, three education sessions, two special sessions and 85 poster presentations.

Read Moffitt’s 2023 AACR Stories 


Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer

The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer 


Are HIV Patients Undertreated for Cancer?

Moffitt investigates potential for interactions between antiretroviral therapy and chemotherapy


Navigating Racial and Ethnic Criteria Appropriately Could Boost Clinical Trial Eligibility

According to researchers, criteria may pose additional barriers to minority cancer patients


Fecal Biobanking Holds Promises for Colorectal Cancer

Moffitt researcher aims to build repository to study gut microbiome